San Jose, CA, United States of America

Sureshbabu Dadiboyena

This inventor holds 1 USPTO granted patent. Top assignee: Reviva Pharmaceuticals, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sureshbabu Dadiboyena. Retrieved from https://idiyas.com/inventor/sureshbabu-dadiboyena

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sureshbabu Dadiboyena: Innovator in Pharmaceutical Chemistry

Introduction: Sureshbabu Dadiboyena, an accomplished inventor based in San Jose, California, has made significant contributions to the field of pharmaceutical chemistry. His innovative research focuses on developing novel compounds that aim to address complex neurological disorders.

Latest Patents: Dadiboyena holds a patent for his groundbreaking work titled "Compositions, synthesis, and methods of utilizing quinazolinedione derivatives." This invention revolves around quinazolinedione derivatives of Formulae Ia and Ib, which offer promising avenues for treating schizophrenia and related psychoses, including acute manic episodes, bipolar disorder, autistic disorder, depression, and dementia.

Career Highlights: Currently, Sureshbabu is employed at Reviva Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical research. His dedication to discovering effective treatments for mental health conditions highlights his commitment to improving patient outcomes.

Collaborations: Throughout his career, Dadiboyena has collaborated with esteemed colleagues, including Laxminarayan Bhat and Prabhu Prasad Mohapatra. These professional relationships have further enriched his research and contributed to the advancement of innovative treatments.

Conclusion: Sureshbabu Dadiboyena stands out as a noteworthy inventor in the pharmaceutical industry, with his patent showcasing his potential to transform the treatment landscape for mental health disorders. His ongoing work at Reviva Pharmaceuticals, Inc., alongside his collaborators, embodies the essence of innovation in tackling some of today's most challenging medical issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…